DNA Methylation of the ABO Promoter Underlies Loss of ABO Allelic Expression in a Significant Proportion of Leukemic Patients

• Tina Bianco-Miotto ,

  * E-mail: tina.bianco-miotto@imvs.sa.gov.au

  Affiliations Department of Haematology-Oncology and University of Adelaide, Discipline of Medicine, The Queen Elizabeth Hospital, Woodville, South Australia, Australia, Dame Roma Mitchell Cancer Research Laboratories, Discipline of Medicine, The University of Adelaide, Hanson Institute, Adelaide, South Australia, Australia

  ⨯
• Damian J. Hussey,

  Affiliations Department of Haematology-Oncology and University of Adelaide, Discipline of Medicine, The Queen Elizabeth Hospital, Woodville, South Australia, Australia, Department of Surgery, Flinders University, Flinders Medical Centre, Bedford Park, South Australia, Australia

  ⨯
• Tanya K. Day,

  Affiliation Department of Haematology-Oncology and University of Adelaide, Discipline of Medicine, The Queen Elizabeth Hospital, Woodville, South Australia, Australia

  ⨯
• Denise S. O'Keefe,

  Affiliation Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Alexander Dobrovic

  Affiliations Department of Haematology-Oncology and University of Adelaide, Discipline of Medicine, The Queen Elizabeth Hospital, Woodville, South Australia, Australia, Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Department of Pathology, University of Melbourne, Melbourne, Victoria, Australia

  ⨯